MedTrace Logo

Blinded Dry Mouth Spray Crossover Study

NCT04608773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2024-02-01

Study results available
· View outcomes & findings →

Summary

To identify the effectiveness of two mouth sprays at relieving symptoms of xerostomia in patients who have received radiation for carcinoma of the head and neck.

To assess patient quality of life and mouth acidity following use of two mouth sprays meant to relieve symptoms of xerostomia in patients who have received radiation for carcinoma of the head and neck.

Conditions

Interventions

OTHER

Remineralizing Extreme Dry Mouth Spray with Xylitol

oral hydrating spray

DEVICE

Alcohol-Free Moisturizing Dry Mouth Spray

oral hydrating spray

Sponsors & Collaborators

  • TJA Health, LLC

    collaborator INDUSTRY

  • Jonas Johnson

    lead OTHER

Principal Investigators

  • Jonas T Johnson, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-14
Primary Completion
2022-11-15
Completion
2023-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04608773 on ClinicalTrials.gov